High Pressure Non Invasive Ventilation in Hypercapnic Respiratory Failure
1 other identifier
observational
52
0 countries
N/A
Brief Summary
High pressure NIV is a pressure limited ventilation, stating IPAP pressure at 20 cmH2O and gradually increasing pressure up to 30 cmH2O according to patient tolerance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2020
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 23, 2020
CompletedFirst Posted
Study publicly available on registry
April 27, 2020
CompletedStudy Start
First participant enrolled
August 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2023
CompletedJuly 13, 2020
July 1, 2020
1.7 years
April 23, 2020
July 10, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
High pressure non invasive ventilation in acute hypercapnic respiratory failure
To study the efficacy of safety of high pressure NIV in acute hypercapnic respiratory failure due to COPD and obesity hypoventilation syndrome who refractory to low pressure NIV.
Patients will assessed after 2 hours from increasing pressure
High pressure non invasive ventilation in acute hypercapnic respiratory failure
Effect of high pressure NIV on length of hospital stay , need for invasive mechanical ventilation, mortality.
Patients will assessed after 2 hours from increasing pressure
Study Arms (1)
High pressure _ low pressure non-invasive ventilation
In the high-pressure NIV,52 patients will undergo pressure-limited NPPV at a higher IPAP level. IPAP is initially set at 20 cmH2O and continuously adjusted by increments and decrements of 1-2 cmH2O (up to 30 cmH2O), according to patients' tolerance, to obtain a tidal volume (VT) of 15 mL/kg of IBW. 2- EPAP for patients with COPD will be started at EPAP 5 and will be increased till 7 and for the patients with hypoventilation syndrome will be increased up to EPAP 8. 3-Respiratory rate 10-12 b/min.
Interventions
Usage of High pressure non invasive ventilation in acute hypercapnic respiratory failure
Eligibility Criteria
Patients who failed on low pressure NIV will be shifted to high pressure NIV with any of these
You may qualify if:
- All patients admitted in Assiut University Hospital and Assiut Police Hospital with acute hypercapnic respiratory failure due to COPD and Obesity hypoventilation syndrome (OHS) indicated for conventional NIV.
- Patients who failed on low pressure NIV will be shifted to high pressure NIV with any of these conditions:
- PH \<7.30 or less than admission level.
- RR \> 35b/m or more than admission level.
- SpO2 \< 88%.
You may not qualify if:
- Age \<18 years.
- Excessive amount of respiratory secretions or weak cough.
- Upper airway obstruction.
- Recent oral, facial or cranial trauma or surgery.
- Sever abdominal distension.
- Active upper gastrointestinal bleeding.
- Cardiac or respiratory arrest.
- PH\<7.25.
- Arterial oxygen tension /fraction of inspired oxygen (PaO2 / FiO2) \<150mmHg.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Khaled Hu Ahmed
Professor of chest diseases Faculty of medicine Assiut university
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Lecturer
Study Record Dates
First Submitted
April 23, 2020
First Posted
April 27, 2020
Study Start
August 1, 2020
Primary Completion
April 1, 2022
Study Completion
April 1, 2023
Last Updated
July 13, 2020
Record last verified: 2020-07